The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Patients with panel reactive antibodies have many difficulties to find a crossmatch-negative
kidney for transplantation and are at the risk of post transplantation rejection more than
other transplanted patients. We evaluated the effect of simvastatin on PRA and post
transplant outcome of these sensitized patients. We also performed a descriptive study.